Skip to main content
Top
Published in: Cancer Chemotherapy and Pharmacology 6/2010

01-11-2010 | Original Article

Sonodynamically induced apoptosis and active oxygen generation by gallium–porphyrin complex, ATX-70

Authors: Nagahiko Yumita, Kazuho Okudaira, Yasunori Momose, Shin-ichiro Umemura

Published in: Cancer Chemotherapy and Pharmacology | Issue 6/2010

Login to get access

Abstract

In this study, we investigated the induction of apoptosis by ultrasound in the presence of the photochemically active gallium–porphyrin complex, 7,12-bis(1-decyloxyethyl)-Ga(III)-3,8,13,17-tetramethyl-porphyrin 2,18-dipropionyl diaspartic acid (ATX-70). HL-60 cells were exposed to ultrasound for up to 3 min in the presence and absence of ATX-70, and the induction of apoptosis was examined by analyzing cell morphology, DNA fragmentation, and caspase-3 activity. Cells treated with 80 μM ATX-70 and ultrasound clearly showed membrane blebbing and cell shrinkage, whereas significant morphologic changes were not observed in cells exposed to either ultrasound or ATX-70 alone. Also, DNA ladder formation and caspase-3 activation were observed in cells treated with both ultrasound and ATX-70 but not in cells treated with ultrasound or ATX-70 alone. In addition, the combination of ATX-70 and the same acoustical arrangement of ultrasound substantially enhanced nitroxide generation by the cells. Sonodynamically induced apoptosis, caspase-3 activation, and nitroxide generation were significantly suppressed by histidine. These results indicate that the combination of ultrasound and ATX-70 induces apoptosis in HL-60 cells. The significant reduction in sonodynamically induced apoptosis, nitroxide generation, and caspase-3 activation by histidine suggests that active species such as singlet oxygen are important in the sonodynamic induction of apoptosis.
Literature
2.
go back to reference Lele PP (1982) Local hyperthermia by ultrasound. In: Nussbaum GH (ed) Physical Aspect of Hyperthermia. American Institute of Physics, New York, pp 393–440 Lele PP (1982) Local hyperthermia by ultrasound. In: Nussbaum GH (ed) Physical Aspect of Hyperthermia. American Institute of Physics, New York, pp 393–440
3.
go back to reference Rosenthal I, Sostaric ZJ, Riesz P (2004) Sonodynamic therapy—a review of the synergistic effects of drugs and ultrasound. Ultrason Sonochem 11:349–363PubMed Rosenthal I, Sostaric ZJ, Riesz P (2004) Sonodynamic therapy—a review of the synergistic effects of drugs and ultrasound. Ultrason Sonochem 11:349–363PubMed
4.
go back to reference Yu T, Wang Z, Mason TJ (2004) A review of research into the uses of low level ultrasound in cancer therapy. Ultrason Sonochem 11:95–103CrossRefPubMed Yu T, Wang Z, Mason TJ (2004) A review of research into the uses of low level ultrasound in cancer therapy. Ultrason Sonochem 11:95–103CrossRefPubMed
5.
go back to reference Umemura S, Kawabata K, Sasaki K, Yumita N, Umemura K, Nishigaki R (1996) Recent advances in sonodynamic approach to cancer therapy. Ultrason Sonochem 3:S187–S191CrossRef Umemura S, Kawabata K, Sasaki K, Yumita N, Umemura K, Nishigaki R (1996) Recent advances in sonodynamic approach to cancer therapy. Ultrason Sonochem 3:S187–S191CrossRef
6.
go back to reference Tachibana K, Uchida T, Hisano S, Morioka E (1997) Eliminating adult T-cell leukaemia cells with ultrasound. Lancet 349:9048CrossRef Tachibana K, Uchida T, Hisano S, Morioka E (1997) Eliminating adult T-cell leukaemia cells with ultrasound. Lancet 349:9048CrossRef
7.
go back to reference Abe H, Kuroki M, Tachibana K, Li T, Awasthi A, Ueno A, Matsumoto H, Imakiire T, Yamauchi Y, Yamada H, Ariyoshi A, Kuroki M (2002) Targeted sonodynamic therapy of cancer using a photosensitizer conjugated with antibody against carcinoembryonic antigen. Anticancer Res 22:1575–1580PubMed Abe H, Kuroki M, Tachibana K, Li T, Awasthi A, Ueno A, Matsumoto H, Imakiire T, Yamauchi Y, Yamada H, Ariyoshi A, Kuroki M (2002) Targeted sonodynamic therapy of cancer using a photosensitizer conjugated with antibody against carcinoembryonic antigen. Anticancer Res 22:1575–1580PubMed
8.
go back to reference Bellnier DA, Ho YK, Panday RK, Missert JR, Dougherty TJ (1989) Distribution and elimination of Photofrin II in mice. Photochem Photobiol 50:221–228CrossRefPubMed Bellnier DA, Ho YK, Panday RK, Missert JR, Dougherty TJ (1989) Distribution and elimination of Photofrin II in mice. Photochem Photobiol 50:221–228CrossRefPubMed
10.
go back to reference Umemura S, Yumita N, Nishigaki R (1993) Enhancement of ultrasonically induced cell damage by a gallium–porphyrin complex, ATX70. Jpn J Cancer Res 84:582–588PubMed Umemura S, Yumita N, Nishigaki R (1993) Enhancement of ultrasonically induced cell damage by a gallium–porphyrin complex, ATX70. Jpn J Cancer Res 84:582–588PubMed
11.
go back to reference Umemura S, Yumita N, Nishigaki R, Umemura S (1990) Mechanism of cell damage by ultrasound in combination with hematoporphyrin. Jpn J Cancer Res 81:962–966PubMed Umemura S, Yumita N, Nishigaki R, Umemura S (1990) Mechanism of cell damage by ultrasound in combination with hematoporphyrin. Jpn J Cancer Res 81:962–966PubMed
12.
go back to reference Umemura K, Yumita N, Nishigaki R, Umemura S (1996) Sonodynamically induced antitumor effect of pheophorbide a. Cancer Lett 102:151–157CrossRefPubMed Umemura K, Yumita N, Nishigaki R, Umemura S (1996) Sonodynamically induced antitumor effect of pheophorbide a. Cancer Lett 102:151–157CrossRefPubMed
13.
go back to reference Yumita N, Nishigaki R, Sakata I, Nakajima S, Umemura S (2000) Sonodynamically induced antitumor effect of 4-formyloximethylidene-3-hydroxy-2-vinyl-deuterio-porphynyl(IX)-6, 7-diaspartic acid (ATX-S10). Jpn J Cancer Res 91:255–260PubMed Yumita N, Nishigaki R, Sakata I, Nakajima S, Umemura S (2000) Sonodynamically induced antitumor effect of 4-formyloximethylidene-3-hydroxy-2-vinyl-deuterio-porphynyl(IX)-6, 7-diaspartic acid (ATX-S10). Jpn J Cancer Res 91:255–260PubMed
14.
go back to reference Yumita N, Umemura S, Nishigaki R (2000) Ultrasonically induced cell damage enhanced by photofrin II: mechanism of sonodynamic activation. In Vivo 14:425–429PubMed Yumita N, Umemura S, Nishigaki R (2000) Ultrasonically induced cell damage enhanced by photofrin II: mechanism of sonodynamic activation. In Vivo 14:425–429PubMed
15.
go back to reference Yumita N, Nishigaki R, Umemura S (2000) Sonodynamically induced antitumor effect of photofrin II on colon 26 carcinoma. Cancer Res Clin Oncol 126:601–606CrossRef Yumita N, Nishigaki R, Umemura S (2000) Sonodynamically induced antitumor effect of photofrin II on colon 26 carcinoma. Cancer Res Clin Oncol 126:601–606CrossRef
16.
go back to reference Yumita N, Sasaki K, Umemura S, Nishigaki R (1996) Sonodynamically induced antitumor effect of a gallium-porphyrin complex, ATX-70. Jpn J Cancer Res 87:310–316PubMed Yumita N, Sasaki K, Umemura S, Nishigaki R (1996) Sonodynamically induced antitumor effect of a gallium-porphyrin complex, ATX-70. Jpn J Cancer Res 87:310–316PubMed
17.
go back to reference Yumita N, Umemura S (2003) Sonodynamic therapy with photofrin II on AH130 solid tumor. Pharmacokinetics, tissue distribution and sonodynamic antitumoral efficacy of photofrin II. Cancer Chemother Pharmacol 51:174–178PubMed Yumita N, Umemura S (2003) Sonodynamic therapy with photofrin II on AH130 solid tumor. Pharmacokinetics, tissue distribution and sonodynamic antitumoral efficacy of photofrin II. Cancer Chemother Pharmacol 51:174–178PubMed
18.
go back to reference Nakajima S, Hayashi H, Sakata I, Takemura K (1993) New photosensitizer ATX-S10 having Type I photoreaction. J Clin Exp Med (Igaku no Ayumi) 164:187–188 (in Japanese) Nakajima S, Hayashi H, Sakata I, Takemura K (1993) New photosensitizer ATX-S10 having Type I photoreaction. J Clin Exp Med (Igaku no Ayumi) 164:187–188 (in Japanese)
19.
go back to reference Yamamoto J, Hirano T, Li S, Koide M, Kohno E, Inenaga C, Tokuyama T, Yokota N, Yamamoto S, Terakawa S, Namba H (2005) Selective accumulation and strong photodynamic effects of a new photosensitizer, ATX-S10. Na(II), in experimental malignant glioma. Int J Oncol 27:1207–1213PubMed Yamamoto J, Hirano T, Li S, Koide M, Kohno E, Inenaga C, Tokuyama T, Yokota N, Yamamoto S, Terakawa S, Namba H (2005) Selective accumulation and strong photodynamic effects of a new photosensitizer, ATX-S10. Na(II), in experimental malignant glioma. Int J Oncol 27:1207–1213PubMed
20.
21.
go back to reference Wyllie AH (1980) Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284:555–556CrossRefPubMed Wyllie AH (1980) Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284:555–556CrossRefPubMed
22.
go back to reference Vantieghem A, Assefa Z, Vandenabeel P (1998) Hypericin-induced photosensitization of HeLa cells leads to apoptosis or necrosis. Involvement of cytochrome c and procaspase-3 activation in the mechanism of apoptosis. FEBS Lett 440:19–24CrossRefPubMed Vantieghem A, Assefa Z, Vandenabeel P (1998) Hypericin-induced photosensitization of HeLa cells leads to apoptosis or necrosis. Involvement of cytochrome c and procaspase-3 activation in the mechanism of apoptosis. FEBS Lett 440:19–24CrossRefPubMed
23.
go back to reference Feril LB Jr, Kondo T, Takaya K, Riesz P (2004) Enhanced ultrasound-induced apoptosis and cell lysis by a hypotonic medium. Int J Radiat Biol 80:165–175CrossRefPubMed Feril LB Jr, Kondo T, Takaya K, Riesz P (2004) Enhanced ultrasound-induced apoptosis and cell lysis by a hypotonic medium. Int J Radiat Biol 80:165–175CrossRefPubMed
24.
go back to reference Feril LB Jr, Tsuda Y, Kondo T, Zhao QL, Ogawa R, Cui ZG, Tsukada K, Riesz P (2004) Ultrasound-induced killing of monocytic U937 cells enhanced by 2, 2’-azobis(2-amidinopropane) dihydrochloride. Cancer Sci 95:181–185CrossRefPubMed Feril LB Jr, Tsuda Y, Kondo T, Zhao QL, Ogawa R, Cui ZG, Tsukada K, Riesz P (2004) Ultrasound-induced killing of monocytic U937 cells enhanced by 2, 2’-azobis(2-amidinopropane) dihydrochloride. Cancer Sci 95:181–185CrossRefPubMed
25.
go back to reference Feril LB Jr, Kondo T, Ogawa R, Zhao QL (2003) Dose-dependent inhibition of ultrasound-induced cell killing and free radical production by carbon dioxide. Ultrason Sonochem 10:81–84CrossRefPubMed Feril LB Jr, Kondo T, Ogawa R, Zhao QL (2003) Dose-dependent inhibition of ultrasound-induced cell killing and free radical production by carbon dioxide. Ultrason Sonochem 10:81–84CrossRefPubMed
26.
go back to reference Ashush H, Rozenszajn LA, Blass M, Barda-Saad M, Azimov D, Radnay J, Zipori D, Rosenschein U (2000) Apoptosis induction of human myeloid leukemic cells by ultrasound exposure. Cancer Res 60:1014–1020PubMed Ashush H, Rozenszajn LA, Blass M, Barda-Saad M, Azimov D, Radnay J, Zipori D, Rosenschein U (2000) Apoptosis induction of human myeloid leukemic cells by ultrasound exposure. Cancer Res 60:1014–1020PubMed
27.
go back to reference Lagneaux L, de Meulenaer EC, Delforge A, Dejeneffe M, Massy M, Moerman C, Hannecart B, Canivet Y, Lepeltier MF, Bron D (2002) Ultrasonic low-energy treatment: a novel approach to induce apoptosis in human leukemic cells. Exp Hematol 30:1293–1301CrossRefPubMed Lagneaux L, de Meulenaer EC, Delforge A, Dejeneffe M, Massy M, Moerman C, Hannecart B, Canivet Y, Lepeltier MF, Bron D (2002) Ultrasonic low-energy treatment: a novel approach to induce apoptosis in human leukemic cells. Exp Hematol 30:1293–1301CrossRefPubMed
28.
go back to reference Ando H, Feril LB Jr, Kondo T, Tabuchi Y, Ogawa R, Zhao QL, Cui ZG, Umemura S, Yoshikawa H, Misaki T (2006) An echo-contrast agent, Levovist, lowers the ultrasound intensity required to induce apoptosis of human leukemia cells. Cancer Lett 242:37–45CrossRefPubMed Ando H, Feril LB Jr, Kondo T, Tabuchi Y, Ogawa R, Zhao QL, Cui ZG, Umemura S, Yoshikawa H, Misaki T (2006) An echo-contrast agent, Levovist, lowers the ultrasound intensity required to induce apoptosis of human leukemia cells. Cancer Lett 242:37–45CrossRefPubMed
29.
go back to reference Feril LB Jr, Kondo T, Zhao QL, Ogawa R, Tachibana K, Kudo N, Fujimoto S, Nakamura S (2003) Enhancement of ultrasound-induced apoptosis and cell lysis by echo-contrast agents. Ultrasound Med Biol 29:331–337CrossRefPubMed Feril LB Jr, Kondo T, Zhao QL, Ogawa R, Tachibana K, Kudo N, Fujimoto S, Nakamura S (2003) Enhancement of ultrasound-induced apoptosis and cell lysis by echo-contrast agents. Ultrasound Med Biol 29:331–337CrossRefPubMed
30.
go back to reference Kim T, Jung U, Cho DY, Chung AS (2001) Se-methylselenocysteine induces apoptosis mediated by reactive oxygen species in HL-60 cells. Carcinogenesis 22:559–565CrossRefPubMed Kim T, Jung U, Cho DY, Chung AS (2001) Se-methylselenocysteine induces apoptosis mediated by reactive oxygen species in HL-60 cells. Carcinogenesis 22:559–565CrossRefPubMed
31.
go back to reference Foote CS (1991) Definition of type I and type II photosensitized oxidation. Photochem Photobiol 54:659–666CrossRefPubMed Foote CS (1991) Definition of type I and type II photosensitized oxidation. Photochem Photobiol 54:659–666CrossRefPubMed
32.
go back to reference Hiraoka H, Honda H, Feril LB Jr, Kudo N, Kondo T (2006) Comparison between sonodynamic effect and photodynamic effect with photosensitizers on free radical formation and cell killing. Ultrason Sonochem 13:535–542CrossRefPubMed Hiraoka H, Honda H, Feril LB Jr, Kudo N, Kondo T (2006) Comparison between sonodynamic effect and photodynamic effect with photosensitizers on free radical formation and cell killing. Ultrason Sonochem 13:535–542CrossRefPubMed
33.
go back to reference Goldstein S, Czapski G (1984) Mannitol as OH scavenger in aqueous solutions and biological systems. Int J Radiat Biol 46:725–729CrossRef Goldstein S, Czapski G (1984) Mannitol as OH scavenger in aqueous solutions and biological systems. Int J Radiat Biol 46:725–729CrossRef
34.
go back to reference Misik V, Riesz P (2000) Free radical intermediates in sonodynamic therapy. Ann N Y Acad Sci 899:335–348CrossRefPubMed Misik V, Riesz P (2000) Free radical intermediates in sonodynamic therapy. Ann N Y Acad Sci 899:335–348CrossRefPubMed
Metadata
Title
Sonodynamically induced apoptosis and active oxygen generation by gallium–porphyrin complex, ATX-70
Authors
Nagahiko Yumita
Kazuho Okudaira
Yasunori Momose
Shin-ichiro Umemura
Publication date
01-11-2010
Publisher
Springer-Verlag
Published in
Cancer Chemotherapy and Pharmacology / Issue 6/2010
Print ISSN: 0344-5704
Electronic ISSN: 1432-0843
DOI
https://doi.org/10.1007/s00280-010-1264-6

Other articles of this Issue 6/2010

Cancer Chemotherapy and Pharmacology 6/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine